Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes

Vaccine

Volumn 27, Issue 2, 2009, Pages 260-269

  Niesalla, H ^c   de Andres X ^a   Barbezange, C ^b   Fraisier, C ^g   Reina, R ^a   Arnarson, H ^d   Biescas, E ^e   Mazzei, M ^f   McNeilly, T N ^c   Liu, C ^c   Watkins, C ^c   Perez, M ^e   Carrozza, M L ^f   Bandecchi, P ^h   Solano, C ^a   Crespo, H ^a   Glaria, I ^a   Huard, C ⁱ   Shaw, D J ^c   de Blas, I ^e   de Andres D ^a   Tolari, F ^f   Rosati, S ^h   Suzan Monti, M ^g   Andresdottir V ^d   Torsteinsdottir, S ^d   Petursson, G ^d   Badiola, J ^a   Lujan, L ^e   Pepin, M ⁱ   Amorena, B ^a   Blacklaws, B ^b   Harkiss, G D ^c   more..

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF ICELAND   (Iceland)

^e UNIVERSITY OF ZARAGOZA   (Spain)

^f UNIVERSITY OF PISA   (Italy)

^g AIX MARSEILLE UNIVERSITY   (France)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ Healthy Pigs Production and Experimentation Section   (France)

Author keywords

DNA vaccination; Gene gun; Immune response; Lentivirus; Particle mediated epidermal bombardment; Sheep

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; PLASMID DNA; PROTEIN P25; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLOOD; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE GUN; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; LENTIVIRINAE; LUNG; MALE; MEDIASTINUM LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; VIRUS LOAD; VISNA VIRUS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BIOLISTICS; EPIDERMIS; FEMALE; GENES, ENV; GENES, GAG; IMMUNIZATION; MALE; PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP; PROVIRUSES; SHEEP; T-LYMPHOCYTES; VACCINES, DNA; VACCINIA VIRUS; VIRAL VACCINES; VIRION; VISNA-MAEDI VIRUS;

EID: 57149115749     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.042     Document Type: Article

References (40)

1. Clements J.E., and Narayan O. Biology and pathogenesis of lentiviruses. J Gen Virol 70 (1989) 1617-1639
2. Narayan O., Kennedy-Stoskopf S., Sheffer D., Griffin D.E., and Clements E. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun 41 (1983) 67-73
3. Gendelman H.E., Narayan O., Molineaux S., Clements J.E., and Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA 82 (1985) 7086-7090
4. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., Kennedy P.G., Ghotbi Z., Clements J.E., et al. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 58 (1986) 67-74
5. Nathanson N., Martin J.R., Georgsson G., Palsson P.A., Lutley R.E., and Petursson G. The effect of post-infection immunization on the severity of experimental visna. J Comp Pathol 91 (1981) 185-191
6. McGuire T.C., Adams D.S., Johnson G.C., Klevjer-Anderson P., Barbee D.D., and Gorham J.R. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am J Vet Res 47 (1986) 537-540
7. Cutlip R.C., Lehmkuhl H.D., Brogden K.A., and Schmerr M.J. Failure of experimental vaccines to protect against infection with ovine progressive pneumonia (maedi-visna) virus. Vet Microbiol 13 (1987) 201-204
8. Nenci C., Zahno M.L., Vogt H.R., Obexer-Ruff G., Doherr M.G., et al. Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo. J Gen Virol 88 (2007) 1589-1593
9. Nathanson N., Panitch H., Palsson P.A., Petursson G., and Georgsson G. Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest 35 (1976) 444-451
10. Eriksson K., McInnes E., Ryan S., Tonks P., McConnell I., and Blacklaws B. CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo. Virology 258 (1999) 355-364
11. Kemp R.K., Knowles D.P., Perry L.L., McGuire T.C., Besser T.E., and Cheevers W.P. Crossreactive neutralizing antibodies induced by immunization with caprine arthritis-encephalitis virus surface glycoprotein. Vaccine 18 (2000) 1282-1287
12. Cheevers W.P., Snekvik K.R., Trujillo J.D., Kumpula-McWhirter N.M., Pretty On Top K.J., and Knowles D.P. Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis. Virology 306 (2003) 116-125
13. Fuller D.H., Loudon P., and Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40 (2006) 86-97
14. Trimble C., Lin C.T., Hung C.F., Pai S., Juang J., He L., et al. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21 (2003) 4036-4042
15. Kamili S., Spelbring J., Carson D., and Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 189 (2004) 258-264
16. Asakura Y., Lundholm P., Kjerrström A., Benthin R., Lucht E., Fukushima J., et al. DNA-plasmids of HIV-1 induce systemic and mucosal immune responses. Biol Chem 380 (1999) 375-379
17. Loehr B.I., Willson P., Babiuk L.A., and van Drunen Littel-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J Virol 74 (2000) 6077-6086
18. Fuller D.H., Rajakumar P.A., Wilson L.A., Trichel A.M., Fuller J.T., Shipley T., et al. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine. J Virol 76 (2002) 3309-3317
19. González B., Reina R., García I., Andrés S., Glaria I., Alzueta M., et al. Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection. Vaccine 23 (2005) 4342-4352
20. Rothel J.S., Boyle D.B., Both G.W., Pye A.D., Waterkeyn J.G., Wood P.R., et al. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol 19 (1997) 221-227
21. Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., and Ramshaw I.A. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 72 (1998) 10180-10188
22. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., et al. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 16 (1998) 439-445
23. Scheerlinck J.Y. Genetic adjuvants for DNA vaccines. Vaccine 19 (2001) 2647-2656
24. Reina R., Barbezange C., Niesalla H., de Andrés X., Arnarson H., Biescas E., et al. Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes. Vaccine 26 (2008) 4494-4505
25. Sargan D.R., Bennet I.D., Cousens C., Roy D.J., Blacklaws B.A., Dalziel R.G., et al. Nucleotide sequence of EV1, a British isolate of maedi visna virus. J Gen Virol 72 (1991) 1893-1903
26. Bird P., Blacklaws B., Reyburn H.T., Allen D., Hopkins J., Sargan D., et al. Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. J Virol 67 (1993) 5187-5197
27. Fraisier C., Arnason H., Barbezange C., Andresdottir V., Carrozza M.L., De Andres, et al. Expression of the gp150 Maedi Visna Virus envelope precursor protein by mammalian expresión vectors. J Virol Methods 146 (2007) 363-367
28. Watkins C., Hopkins J., and Harkiss G. Reporter gene expression in dendritic cells after gene gun administration of plasmid DNA. Vaccine 23 (2005) 4247-4256
29. Singh I., McConnell I., and Blacklaws B. Immune response to individual maedi-visna virus gag antigens. J Virol 80 (2006) 912-919
30. McNeilly T.N., Tennant P., Lujan L., Perez M., and Harkiss G.D. Differential infection efficiencies of peripheral lung and tracheal tissues in sheep infected with visna/maedi virus via the respiratory tract. J Gen Virol 88 (2007) 670-679
31. Blacklaws B.A., Bird P., Allen D., and McConnell I. Circulating cytotoxic T lymphocyte precursors in maedi-visna virus-infected sheep. J Gen Virol 75 (1994) 1589-1596
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) 2002-2007
33. Toapanta F.R., Craigo J.K., Montelaro R.C., and Ross T.M. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Curr HIV Res 5 (2007) 199-209
34. Kawada M., Tsukamoto T., Yamamoto H., Takeda A., Igarashi H., Watkins D.I., et al. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine. J Virol 81 (2007) 5202-5211
35. Yamamoto H., Kawada M., Tsukamoto T., Takeda A., Igarashi H., Miyazawa M., et al. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. J Gen Virol 88 (2007) 652-659
36. Huang Y., Babiuk L.A., and van Drunen Littel-van den Hurk S. The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection. Vaccine 24 (2006) 5349-5359
37. Peters B.S., Jaoko W., Vardas E., Panayotakopoulos G., Fast P., Schmidt C., et al. Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity. Vaccine 25 (2007) 2120-2127
38. Hanke T., McMichael A.J., and Dorrell L. Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction. J Gen Virol 88 (2007) 1-12
39. Knowles Jr. D., Cheever W., McGuire T., Stem T., and Gorham J. Severity of arthritis is predicted by antibody response to gp135 in chronic infection with caprine arthritis-encephalitis virus. J Virol 64 (1990) 2396-2398
40. Kiepeila P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13 (2007) 46-53